SCHEMBL6949066

SCHEMBL6949066

Cc1cnc(N2CCc3ccccc3CC2)c([N+](=O)[O-])c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 3/20 0.49
ALDH1A1 P00352 1/20 0.49
HTT P42858 1/20 0.49
GRM5 P41594 2/20 0.48
LMNA P02545 3/20 0.48
NPC1 O15118 1/20 0.46
RAB9A P51151 1/20 0.46
POLB P06746 1/20 0.46
GRIN2D O15399 2/20 0.46
GRIN3B O60391 2/20 0.46
GRIN1 Q05586 2/20 0.46
GRIN2A Q12879 2/20 0.46
GRIN2B Q13224 2/20 0.46
GRIN2C Q14957 2/20 0.46
GRIN3A Q8TCU5 2/20 0.46
EED O75530 1/20 0.46
MAPT P10636 4/20 0.46
PKM P14618 1/20 0.46
CYP1A2 P05177 2/20 0.45
CYP2C9 P11712 2/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6948430 0.85 MAPK1 (0.68) MAPK1ALDH1A1HTTGRM5LMNA
SCHEMBL1736068 0.79 MAPT (0.52) MAPK1ALDH1A1HTTLMNANPC1
SCHEMBL6951312 0.78 LMNA (0.76) MAPK1ALDH1A1GRM5LMNANPC1
SCHEMBL3435641 0.77 ALDH1A1 (0.50) MAPK1ALDH1A1HTTGRM5POLB
SCHEMBL20524637 0.76 ALDH1A1 (0.49) MAPK1ALDH1A1HTTGRM5LMNA
SCHEMBL13999697 0.75 ALDH1A1 (0.48) MAPK1ALDH1A1HTTGRM5POLB
SCHEMBL3435982 0.73 ALDH1A1 (0.45) MAPK1ALDH1A1HTTGRM5LMNA
SCHEMBL1735993 0.72 NPC1 (0.69) MAPK1ALDH1A1GRM5LMNANPC1
SCHEMBL30323135 0.71 MAPT (0.53) MAPK1ALDH1A1HTTLMNAPOLB
SCHEMBL22712080 0.71 MAPT (0.53) MAPK1ALDH1A1HTTLMNAPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1074549-B1 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors HOFFMANN LA ROCHE (CH) 2003-11-19 EP disclosed
US-6218385-B1 FOR THERAPY OR PROPHYLAXIS OF ACUTE AND/OR CHRONIC NEUROLOGICAL DISORDERS SUCH AS EPILEPSY, STROKE, CHRONIC AND ACUTE PAIN, PSYCHOSIS, SCHIZOPHRENIA, ALZHEIMER'S DISEASE, COGNITIVE DISORDERS AND MEMORY DEFICITS HOFFMANN-LA ROCHE INC. 2001-04-17 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed